Sarah Enslin
Physician Assistant · Rochester, NYNPI 1730389917
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $48,571 of the $73,635 with a category attached, or 66.0%. 19 manufacturers reported payments, led by Ironwood Pharmaceuticals, Inc at 31.0% of the total. Reporting peaked in 2024 at $44,007 and has fallen 50.1% since, to $21,940 in 2025. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $541.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironwood Pharmaceuticals, Inc$23K
- Johnson & Johnson$19K
- Takeda Pharmaceuticals U.S.A., Inc.$7K
- AbbVie$7K
- GSK$6K
- Exact Sciences$6K
- plus $7K from 13 others
What the payments were for
- Consulting fees$48,57166%
- Speaking & faculty fees$13,69519%
- Travel & lodging$5,7268%
- Food & beverage$5,6328%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironwood Pharmaceuticals, Inc | 16 | $22,862 |
| Johnson & Johnson(2 entities) | 35 | $18,828 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $6,785 |
| AbbVie | 7 | $6,585 |
| GSK | 4 | $5,925 |
| Exact Sciences | 21 | $5,851 |
| Novo Nordisk | 4 | $2,541 |
| Regeneron Healthcare Solutions, Inc. | 12 | $2,021 |
| Ardelyx, Inc. | 3 | $616 |
| Phathom Pharmaceuticals, Inc. | 8 | $480 |
| Steris Corporation | 3 | $477 |
| Boston Scientific | 1 | $191 |
| Janssen Scientific Affairs, LLC | 1 | $147 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $112 |
| Gilead | 1 | $75 |
| Ferring Pharmaceuticals Inc. | 1 | $62 |
| Aimmune Therapeutics, Inc. | 1 | $36 |
| AstraZeneca | 1 | $24 |
| Micro-tech Endoscopy USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$18,025
- STELARA$6,522
- Cologuard Collection Kit$5,346
- Creon$4,610
- LINZESS$3,219
- DUPIXENT$1,717
- Entyvio$531
- IBSRELA$500
- TRUFREEZE$318
- VOQUEZNA$257
- GENERAL - BILIARY DEVICES$191
- The Cologuard Plus Collection Kit$105
How this compares
$73,635 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 77 | $139,565 |
| LinzessLinaclotide | 44 | $28,328 |
| TrulancePlecanatide | 12 | $10,482 |
| Ursodiol | 45 | $10,281 |
| Mesalamine | 12 | $8,967 |
| Dexlansoprazole DrDexlansoprazole | 29 | $7,504 |
| Budesonide DrBudesonide | 25 | $7,480 |
| Omeprazole | 248 | $3,318 |
| NexiumEsomeprazole Magnesium | 12 | $3,247 |
| Pantoprazole Sodium | 243 | $3,018 |
| Famotidine | 142 | $2,195 |
| Sucralfate | 45 | $1,194 |
| Lansoprazole | 28 | $1,115 |
| Esomeprazole Magnesium | 31 | $1,079 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 32 | $812 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $6,585 | $167,893121 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $112 | $10,48212 claims |
| AstraZenecaNexium | $24 | $3,24712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Rochester
- Jennifer ServentiRochester$160K
- Bridget SkinnerRochester$25K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.